NEWS: FEBRUARY 2007

-02/09/2007-

Press Release: Tecan and VWR announce a strategic alliance for microarray products and microplate readers. To read press release click here.

Achillion Pharmaceuticals Inc. and Gilead Sciences Inc. halt clinical trials of hepatitis C drug. To read article click here.

Inflazyme Pharmaceuticals Ltd. to cut 70% of its work force. To read article click here.

-02/08/2007-

Telik Inc. grants exclusive licence of C243 to SRI International for the treatment of multiple sclerosis and other autoimmune and inflammatory diseases. To read article click here.

FDA approves GlaxoSmithKline's non-prescription fat-blocking weight-loss pill orlistat. To read article click here.

XenoPort Inc. and GlaxoSmithKline sign agreement to develop and commecialize XP13512 to treat nerve pain and Restless Legs Syndrome. To read article click here.

Advanced Cell Technology Inc. acquires intellectual property assets of Infigen Inc. To read article click here.

-02/07/2007-

FDA grants orphan drug status to ViroPharma Inc.'s Maribavir for the prevention of cytomegalovirus disease. To read article click here.

Biogen Idec begins randomized clinical trials of its anti-CD23 monoclonal antibody lumiliximab for chronic lymphocytic leukemia treatment. To read article click here.

Forest Laboratories terminates antibiotic development and marketing collaboration with Replidyne. To read article click here.

Pfizer to cut jobs in Ireland. To read article click here.

-02/06/2007-

UCB SA and ImClone Systems Inc. terminate development agreement of CDP-791 for lung cancer treatment. To read article click here.

Cambrex Corporation sells its Bioproducts and Biopharma subsidiaries to Lonza Group AG. To read article click here.

European Union grants orphan drug status to BioCryst Pharmaceuticals Inc.'s Fodosine for the treatment of cutaneous T-cell lymphoma. To read article click here.

ViaCell Inc. announces Phase I clinical trial results of CB001. To read article click here.

Ranbaxy Laboratories Ltd. and GlaxoSmithKline sign multiyear research and development agreement. To read article click here.

-02/05/2007-

Press Release: The SFT-250 Supercritical Fluid Extraction / Reaction (SFE/SFR) Processing System from Activotec is designed to perform extractions and run reactions in a range of supercritical fluid media. To read press release click here.

Press Release: Genevac has announced that it has chosen Pittcon 2007 (Chicago, USA) to launch a new addition to its popular miVac sample concentrator range and to display a selection of its market-leading centrifugal evaporator systems. To read press release click here.

Roche Holding AG to increase R&D spending creating to new units in the USA. To read article click here.

Cyclacel Pharmaceuticals Inc. to further develop its cyclin dependent kinase (CDK) inhibitor seliciclib for the treatment of nasopharyngeal cancer. To read article click here.

Threshold Pharmaceuticals Inc. to begin Phase II clinical trials of glufosfamide for small cell lung cancer treatment. To read article click here.

Elbion and Wyeth Pharmaceuticals form phosphodiesterase 10 research collaboration. To read article click here.

-02/02/2007-

Mitsubishi Chemical to acquire Tanabe Seiyaku Company for $4.3 Billion. To read article click here.

Molecular Insight Pharmaceuticals Inc. goes IPO. To read article click here.

Enzon Pharmaceuticals Inc. consolidates its manufacturing operations in Indianapolis, IN. To read article click here.

Genentech Inc. reports positive results in Raptiva Phase IV trials study for and and foot psoriasis treatment. To read article click here.

-02/01/2007-

Press Release: A compact benchtop cellular analysis system from Guava Technologies Inc. has enabled the research group of Dr Christian D Muller at the Universite Louis Pasteur (Strasbourg, France) to rapidly and reliably screen potentially therapeutic molecules and to investigate their biomolecular interactions within living cells. To read press release click here.

Press Release: Velocity11, a leading innovator and top provider of automation solutions, has launched a new website dedicated to providing pharmaceutical, biotech, and genomic research laboratories with an online resource regularly updated with information to help accelerate their research. To read press release click here.

AstraZeneca to cut 3,000 jobs. To read article click here.

Ligand Pharmaceuticals Inc. to cut 267 jobs or 76% of its workforce. To read article click here.

FDA grants orphan drug status to Aastrom Biosciences Inc.'s Tissue Repair Cells for the treatment of a type of heart disease. To read article click here.

SGX Pharmaceuticals Inc. selects its MET tyrosine kinase inhibitor development candidate SGX-523 for preclinical development. To read article click here.

AstraZeneca to acquire Arrow Therapeutics Ltd. for $150 million. To read article click here.

Pfizer to acquire BioRexis Pharmaceutical Corp. To read article click here.